How should cost data in pragmatic randomised trials be analysed?
about
Improving the reporting of pragmatic trials: an extension of the CONSORT statementSample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN893The probability of cost-effectivenessParametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.Yoga versus education for Veterans with chronic low back pain: study protocol for a randomized controlled trialCost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trialYoga vs. physical therapy vs. education for chronic low back pain in predominantly minority populations: study protocol for a randomized controlled trial.Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysisInfluence of the CYP2D6 isoenzyme in patients treated with venlafaxine for major depressive disorder: clinical and economic consequencesDifferences in health care utilisation between elderly from ethnic minorities and ethnic Dutch elderlyRandomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care.Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial.Economic impact of childhood psychiatric disorder on public sector services in Britain: estimates from national survey data.Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choice.Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database.Use of Bayesian Markov Chain Monte Carlo methods to model cost-of-illness data.Protocol for north of England and Scotland study of tonsillectomy and adeno-tonsillectomy in children (NESSTAC). A pragmatic randomised controlled trial comparing surgical intervention with conventional medical treatment in children with recurrent sDepression: an exploratory parallel-group randomised controlled trial of Antenatal guided self help for WomeN (DAWN): study protocol for a randomised controlled trial.Median-based incremental cost-effectiveness ratios with censored dataA comparison of two methods of collecting economic data in primary care.The MATISSE study: a randomised trial of group art therapy for people with schizophreniaRandomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery.Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelingThe INCH-Trial: a multicentre randomized controlled trial comparing the efficacy of conventional open surgery and laparoscopic surgery for incisional hernia repair.The DAMASK trial protocol: a pragmatic randomised trial to evaluate whether GPs should have direct access to MRI for patients with suspected internal derangement of the knee.Costs of shoulder pain in primary care consulters: a prospective cohort study in The Netherlands.Cost-effectiveness of the SEN-concept: Specialized Emergency Nurses (SEN) treating ankle/foot injuries.Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis.Financial impact of reducing door-to-balloon time in ST-elevation myocardial infarction: a single hospital experience.Economic evaluation of nurse practitioners versus GPs in treating common conditions.Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in SpainStatistical analysis of cost-effectiveness data from randomized clinical trials.Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settingsHealth costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings.Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial
P2860
Q24602353-FC54FD0B-D4DF-4EAE-9C4F-54F68A6F13E9Q24792814-6542C5E6-A8C3-40F4-9BC7-1DD25591D435Q24798085-5BA54ED6-F170-409A-98A0-1D5B95EEA08BQ24801915-DC827103-9457-4F50-9661-E7179B9CEB1FQ24805121-97E0550A-2B48-499E-93AE-5B056D41138AQ24816156-8D29B68C-7F2A-4CBD-9B4B-B42CF03983FFQ27334106-517343A6-EAF2-4FF5-9DF3-C911135EF7CCQ28194967-6AA325B0-1BE9-4825-8897-26F140FBAB2CQ28397024-842E2DFD-C5D8-44AC-ACF3-81FC21A3C06FQ28472043-FB8DA551-9F96-4C34-A41C-41DC05B42CEAQ28544689-56722B31-CF2F-41F9-BE98-A546E697BD63Q29353687-109DB071-FC47-460C-93C7-7820D051FD34Q30482183-F6D2B325-BF3A-41E8-A77C-F2C239779C9AQ30539810-AD4B6C57-88FB-4E7E-9E3C-99F49702C314Q30594534-B16ED35A-0E8B-45F0-B65E-B0A374F19859Q30620791-6D99D648-6813-4094-A650-E4958C71D839Q30717228-5D252FBA-789A-4E2A-9351-AE249531CFE5Q30724023-ADD90E4D-C7D4-41F7-9813-5F7A3AF01367Q30768819-AE32ECF1-EB28-452F-9C5E-7040944A9B21Q30821242-B90C1015-6C75-4882-96B2-815D06267E7AQ30824542-B06ABC60-5FD2-47E5-B75F-FE2CE885D543Q30958552-0828795E-D547-41F7-8F97-4A80E2EB968CQ30986956-ECAD11EB-B161-47B0-AD5B-B3A4266F1C64Q30988171-F50FE1B7-6B9C-485C-BB87-1BC06F3EF96EQ31090070-DB223B60-EAC7-4EC6-AE42-6D89809A0778Q31119280-6239C7EA-4926-42B9-BA07-31773745025CQ31150179-2FDF9902-7547-45B9-82E8-10AF8C753BE0Q33260367-0FE560E9-235B-46D0-AE2C-464997893958Q33262378-4F6DF07A-696F-4E8E-8AAE-7434BFC71836Q33301064-77908872-A00D-4EDE-90CB-38BA3ACFE6B7Q33392179-B716EC81-3808-403B-AEBE-5B0BB5A4BDC8Q33486763-98481EB4-B2EA-42DF-8DD5-81D9EBFC188CQ33572010-57FE6365-CDDA-4FD6-8EDF-80BE0165562CQ33578200-CC351F7B-DB98-436D-8EC9-A66C12D66613Q33588346-01058304-2D0A-4102-B5C0-F6102EC3C6FEQ33596439-BEBA84BB-A5A4-4D89-94DE-1C9AD7499806Q33619652-78529890-2357-4FC4-B96E-E2874C45E542Q33623045-34BBAFEB-71BD-4838-91C3-ACB911082A97Q33629358-CFE774FE-1FB3-4691-BFA5-68AE2DED9567Q33632299-4F2ABD18-1D1C-43F1-8565-E3EFB7776F11
P2860
How should cost data in pragmatic randomised trials be analysed?
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
How should cost data in pragmatic randomised trials be analysed?
@ast
How should cost data in pragmatic randomised trials be analysed?
@en
type
label
How should cost data in pragmatic randomised trials be analysed?
@ast
How should cost data in pragmatic randomised trials be analysed?
@en
prefLabel
How should cost data in pragmatic randomised trials be analysed?
@ast
How should cost data in pragmatic randomised trials be analysed?
@en
P2860
P1433
P1476
How should cost data in pragmatic randomised trials be analysed?
@en
P2093
S G Thompson
P2860
P304
P356
10.1136/BMJ.320.7243.1197
P407
P50
P577
2000-04-01T00:00:00Z